(Q40839606)

24 September 2017

title

Dose-ranging study of tolterodine in patients with detrusor hyperreflexia (English)

1 reference

24 September 2017

Van Kerrebroeck PE

1

1 reference

24 September 2017

Amarenco G

2

1 reference

24 September 2017

Thüroff JW

3

1 reference

24 September 2017

Madersbacher HG

4

1 reference

24 September 2017

Lock MT

5

1 reference

24 September 2017

Messelink EJ

6

1 reference

24 September 2017

Soler JM

7

1 reference

24 September 2017

publication date

1 January 1998

1 reference

Neurourology and Urodynamics

24 September 2017

published in

1 reference

24 September 2017

volume

17

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

499-512

1 reference

Current concepts in the treatment of disorders of micturition

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Tolterodine--a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Pharmacologic treatment of incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Tolterodine--a new bladder-selective antimuscarinic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6777%281998%2917%3A5%3C499%3A%3AAID-NAU6%3E3.0.CO%3B2-8

10.1002/(SICI)1520-6777(1998)17:5<499::AID-NAU6>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference